Comparing semaglutide once a week to liraglutide once a day as add-on to 1-3 anti-diabetes tablets (OADs) in people with type 2 diabetes

Update Il y a 4 ans
Reference: U1111-1190-5868

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the effect of semaglutide subcutaneous (s.c.) 1.0 mg once-weekly versus liraglutide s.c. 1.2 mg once-daily on glycaemic control after 30 weeks of treatment in subjects with type 2 diabetes.


Inclusion criteria

  • Diabetes Mellitus, Type 2

Links